Earli Inc. is dedicated to transforming cancer treatment by developing a Synthetic Biopsy technology that forces cancer cells to produce synthetic biomarkers using gene therapy. This innovative approach allows for precise localization of cancer through PET scanners, offering a more effective and less invasive diagnostic method compared to traditional biomarker detection. Based in South San Francisco, Earli has received significant funding from prominent investors including Andreessen Horowitz's Bio Fund, Khosla Ventures, and Marc Benioff.
Open Positions
Earli Talent Community
Scientific passion, entrepreneurial spirit, strong communication and multitasking skills
Head of Translational Biology
Ph.D. in Pharmacology, 8+ years leading nonclinical safety programs, strong experience in oncology models and CRO management
Senior Scientist, Bio AI
3+ years of experience in AI/ML, expertise in developing novel GenAI models, and proficiency in bioinformatic analyses
Contract Research Associate/Senior Research Associate, Molecular Analyis
BS degree in Molecular Biology, Biochemistry, or related life sciences field; 1+ years of experience in an industry setting; hands-on experience performing nucleic acid extraction from mammalian cells and tissue samples